We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Mystic Pharmaceuticals’ Intranasal Technology Introduces Solutions In Drug Delivery
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Mystic Pharmaceuticals’ Intranasal Technology Introduces Solutions In Drug Delivery
Technology

Mystic Pharmaceuticals’ Intranasal Technology Introduces Solutions In Drug Delivery

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

Delivery of drugs, biopharmaceuticals and vaccines via the nose offer many compelling advantages including reduced nausea and toxicity and rapid onset. Nasal delivery devices improve patient compliance compared with parenteral administration, by providing improved ease of use via either caregiver-based or self administration, as well as obviating the need for biohazardous disposal of needle sharps.

Delivery of drugs, biopharmaceuticals and vaccines via the nose offer many compelling advantages including reduced nausea and toxicity and rapid onset. Nasal delivery devices improve patient compliance compared with parenteral administration, by providing improved ease of use via either caregiver-based or self administration, as well as obviating the need for biohazardous disposal of needle sharps. Austin, Texas based Mystic Pharmaceuticals is an integrated specialty pharmaceutical company that combines large and small molecule pharmaceuticals, biologic agents and vaccines with their advanced proprietary drug delivery technologies to meet the expanding healthcare demands of the global population. Their ophthalmic, intranasal, otic, oral and lyophilized drug delivery technologies are designed to provide pharmaceutical and biologic products which are lower cost, non-invasive, and simplified self administration for enhanced compliance, safety and convenience.

The need for rapid manufacturing capacity for vaccines has recently emerged as a major consideration for US bio-defense preparedness policy. The life science industry players have taken notice of Mystic’s technology in this arena and the company has been invited to present at OneMedForum NY 2011.

In addition to their innovative, problem-solving intranasal drug delivery technology, Mystic is developing an eye drop device for the ophthalmic market that greatly reduces the problems associated with medication waste and the “wet face syndrome” with the current eye dropper method. Effective eye drop administration from a bottle is further complicated by the challenges of having to tip back the head, while positioning a very small bottle over the eye, while squeezing the bottle with the appropriate level of force. Mystic’s device seeks to alleviate these problems and essentially resolve the dilemma with their eye cup design which aids the user in exact positioning of the device and in holding the eyelid in the optimum position.

More Read

Integrated Health System Adoption: How to Start a Movement
Medtech Technologies Gaining Traction
Vascular closure devices
Obesity’s Outlook Unchanged
What I Learned at the HIMSS Conference About Developments in Health IT for the Rest of 2012

The Mystic team and Timothy Sullivan were recognized in 2008 by Medical Device & Diagnostic Industry Magazine as one of the top 100 notable people in the medical device industry for their accomplishments in drug delivery. Further, the company was featured in the April 2011 issue of OnDrugDelivery.com for their novel advances in drug delivery.

In late 2010, the company was awarded a non-taxable grant of approximately $245,000  under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010. To be eligible for the QTDP program, projects must show reasonable potential to result in new therapies to treat areas of unmet medical need and prevent, detect, or treat chronic or acute disease and conditions.

 

TAGGED:intranasal drug deliverymedical technology
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

eHealthMarketingTechnology

5 Key Features of Healthcare Websites in 2018

July 18, 2018

Strong Deal Flow in Digital Health Defines 1H’14

July 1, 2014
preparing for next pendamic
Technology

Preparing for the Next Pandemic: How Technology is Changing the Game

June 6, 2025
telemedicine kiosk
eHealthTechnology

Telemedicine Kiosks in Ohio: The After-Hours Doctor Visit of the Future

October 26, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?